Age-related epileptic encephalopathies

Handbook of Clinical Neurology

Volumn 107, Issue , 2012, Pages 179-193

  Guerrini, Renzo ^a   Pellock, John M ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epileptic seizures; Etiology; Idiopathic epilepsy; Magnetic resonance imaging; Symptomatic epilepsy

Indexed keywords

EID: 84865590301     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52898-8.00011-2     Document Type: Chapter

References (128)

1. Aicardi J., Chevrie J.J. Atypical benign partial epilepsy of childhood. Dev Med Child Neurol 1982, 24:281-292.
2. Appleton R.E., Peters A.C., Mumford J.P., et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999, 40:1627-1633.
3. Archer H.L., Evans J., Edwards S., et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet 2006, 43:729-734.
4. Arzimanoglou A., French J., Blume W.T., et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009, 8:82-93.
5. Asadi-Pooya A.A., Sharan A., Nei M., et al. Corpus callosotomy. Epilepsy Behav 2008, 13:271-278.
6. Asano E., Chugani D.C., Juhasz C., et al. Surgical treatment of West syndrome. Brain Dev 2001, 23:668-676.
7. Baram T.Z., Mitchell W.G., Tournay A., et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomised, blinded study. Pediatrics 1996, 97:375-379.
8. Beaumanoir A. The Lennox-Gastaut syndrome. Epileptic Syndromes in Infancy, Childhood, and Adolescence 1985, 89-99. John Libbey, London. J. Roger, M. Bureau, C. Dravet (Eds.).
9. Berg A.T., Shinnar S., Levy S.R., et al. How well can epilepsy syndromes be identified at diagnosis? A reassessment 2years after initial diagnosis. Epilepsia 2000, 41:1269-1275.
10. Biraben A., Allain H., Scarabin J.M., et al. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2000, 55:1758.
11. Blume W.T. Lennox-Gastaut syndrome: potential mechanisms of cognitive regression. Ment Retard Dev Disabil Res Rev 2004, 10:150-153.
12. Blume W.T., David R.B., Gomez M.R. Generalized sharp and slow wave complexes - associated clinical features and long-term follow-up. Brain 1973, 96:289-306.
13. Blume W.T., Luders H.O., Mizrahi E., et al. ILAE Commission Report. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001, 42:1212-1218.
14. Bonanni P., Parmeggiani L., Guerrini R. Different neurophysiologic patterns of myoclonus characterize Lennox-Gastaut syndrome and myoclonic astatic epilepsy. Epilepsia 2002, 43:609-615.
15. Buzatu M., Bulteau C., Altuzarra C., et al. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia 2009, 50:68-72.
16. Chiron C., Marchand M.C., Tran A., et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000, 11:1638-1642.
17. Ciardo F., Zamponi N., Specchio N., et al. Autosomal recessive polymicrogyria with infantile spasms and limb deformities. Neuropediatrics 2001, 32:325-329.
18. Claes L., Del-Favero J., Ceulemans B., et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
19. Coleman M., Hart P.N., Randall J., et al. Serotonin levels in the blood and central nervous system of a patient with sudanophilic leukodystrophy. Neuropadiatrie 1977, 8:459-466.
20. Cossette P., Riviello J.J., Carmant L. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study. Neurology 1999, 52:1691-1694.
21. Cowan L.D., Hudson L.S. The epidemiology and natural history of infantile spasms. J Child Neurol 1991, 6:355-364.
22. Dalla Bernardina B., Colamaria V., Capovilla G., et al. Nosological classification of epilepsies in the first three years of life. Epilepsy: An Update on Research and Therapy 1983, 165-183. Alan Liss, New York. G. Nisticò, R. Di Perri, H. Meinardi (Eds.).
23. Deonna T. Cognitive and behavioral manifestations of epilepsy in children. Epilepsy in children 2004, 250-257. Arnold, London. 2nd edn. S.J. Wallace, K. Farrell (Eds.).
24. Depienne C., Arzimanoglou A., Trouillard O., et al. Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat 2006, 27:389.
25. Depienne C., Bouteiller D., Keren B., et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 2009, 5:e1000381.
26. Doose H. Myoclonic-astatic epilepsy. Epilepsy Res Suppl 1992, 6:163-168.
27. Doose H., Sitepu B. Childhood epilepsy in a German city. Neuropediatrics 1983, 14:220-224.
28. Doose H., Gerken H., Leonhardt R., et al. Centrencephalic myoclonic-astatic petit mal. Clinical and genetic investigation. Neuropadiatrie 1970, 2:59-78.
29. Dravet C., Bureau M., Oguni H., et al. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol 2005, 95:71-102.
30. Dulac O. Infantile spasms and West syndrome. Epilepsy: A Comprehensive Textbook 1997, 2277-2283. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
31. Dulac O., Kaminska A. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes. J Child Neurol 1997, 12:S23-S28.
32. Dulac O., Plouin P., Jambaqué I., et al. Spasmes infantiles épileptiques bénins. Rev Electroencephalogr Neurophysiol Clin 1986, 16:371-382.
33. Dulac O., Plouin P., Chiron C. "Benign" form of myoclonic epilepsy in children. Neurophysiol Clin 1990, 20:115-129.
34. Duran M.H., Guimarães C.A., Medeiros L.L., et al. Landau-Kleffner syndrome: long-term follow-up. Brain Dev 2009, 31:58-63.
35. Elia M., Falco M., Ferri R., et al. CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology 2008, 71:997-999.
36. Elterman R.D., Shields W.D., Mansfield K.A., et al. US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001, 57:1416-1421.
37. Engel J. International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001, 42:796-803.
38. Escayg A., MacDonald B.T., Meisler M.H., et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000, 24:343-345.
39. Felbamate Study Group in Lennox-Gastaut Syndrome Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993, 328:29-33.
40. Fleiszar K.A., Daniel W.L., Imrey P.B. Genetic study of infantile spasms with hypsarrhythmia. Epilepsia 1977, 18:55-62.
41. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Neurology 2004, 62:1261-1273.
42. Fujiwara T., Sugawara T., Mazaki-Miyazaki E., et al. Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 2003, 126:531-546.
43. Gaily E., Liukkonen E., Paetau R., et al. Infantile spasms: diagnosis and assessment of treatment response by video-EEG. Dev Med Child Neurol 2001, 43:658-667.
44. Genton P., Dravet C. Lennox-Gastaut syndrome. Epilepsy. A comprehensive textbook 2008, 2417-2427. Lippincott, Williams and Wilkins, Philadelphia. 2nd edn. J. Engel, T.A. Pedley (Eds.).
45. Genton P., Guerrini R., Dravet C. The Lennox-Gastaut syndrome. The Epilepsies. Part II. Handbook of Clinical Neurology 2000, Vol. 73:211-222. Elsevier, Amsterdam. H. Meinardi (Ed.).
46. Glauser T., Kluger G., Sachdeo R., et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008, 70:1950-1958.
47. Grote C.L., Van Slyke P., Hoeppner L.A. Language outcome following multiple subpial transection for Landau-Kleffner syndrome. Brain 1999, 122:561-566.
48. Guerrini R. Epilepsy in children. Lancet 2006, 367:499-524.
49. Guerrini R., Aicardi J. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). Clin Neurophysiol 2003, 20:449-461.
50. Guerrini R., Carrozzo R. Epileptogenic brain malformations: clinical presentation, malformative patterns and indications for genetic testing. Seizure 2001, 10:532-547.
51. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998, 39:S2-S10.
52. Guerrini R., Genton P., Bureau M., et al. Multilobar polymicrogyria, intractable drop attack seizures and sleep-related electrical status epilepticus. Neurology 1998, 51:504-512.
53. Guerrini R., Bonanni P., Rothwell J., et al. Myoclonus and epilepsy. Epilepsy and Movement Disorders 2002, 165-210. Cambridge University Press, Cambridge. R. Guerrini, J. Aicardi, F. Andermann (Eds.).
54. Guerrini R., Moro F., Kato M., et al. Expansion of the first polyA tract of ARX causes infantile spasms and status dystonicus. Neurology 2007, 69:427-433.
55. Guerrini R., Cellini E., Mei D., et al. Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene. Epilepsia 2010, 51:2474-2477.
56. Hancock E.C., Cross H.H. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2009, 3. CD003277.
57. Hancock E., Osborne J.P., Milner P. Treatment of infantile spasms. Cochrane Database Syst Rev 2002, 2. CD001770.
58. Heiskala H., Riikonen R., Santavuori P., et al. West syndrome: individualised ACTH therapy. Brain Dev 1996, 18:456-460.
59. Hirano M., Kunz W.S., Di Mauro Mitochondrial diseases. Epilepsy: A Comprehensive Textbook 2008, 2621-2630. Wolters Kluwer, Philadelphia. 2nd edn. J. Engel, T.A. Pedley (Eds.).
60. Hoffmann-Riem M., Diener W., Benninger C., et al. Nonconvulsive status epilepticus - a possible cause of mental retardation in patients with Lennox-Gastaut syndrome. Neuropediatrics 2000, 31:169-174.
61. Hughes J.R. A review of the relationships between Landau-Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep. Epilepsy Behav 2011, 20:247-253.
62. Hurst D.L. Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 1990, 31:397-400.
63. Jambaqué I., Chiron C., Dumas C., et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000, 38:151-160.
64. Jansen F.E., Sadleir L.G., Harkin L.A., et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 2006, 67:2224-2226.
65. Kaminska A., Ickowicz A., Plouin P., et al. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 1999, 36:15-29.
66. Kato M., Das S., Petras K., et al. Polyalanine expansion of ARX associated with cryptogenic West syndrome. Neurology 2003, 61:267-276.
67. Kivity S., Lerman P., Ariel R., et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004, 45:255-262.
68. Kossoff E.H. Infantile spasms. Neurologist 2010, 16:69-75.
69. Kossoff E.H., Pyzik P.L., McGrogan J.R., et al. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002, 109:780-783.
70. Kossoff E.H., Hartman A.L., Rubenstein J.E., et al. High-dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH. Epilepsy Behav 2009, 14:674-676.
71. Kramer U., Sue W.-C., Mikati M. Focal features in West syndrome indicating candidacy for surgery. Pediatr Neurol 1997, 16:213-217.
72. Lawrence K.M., Mei D., Newton M.R., et al. Familial Lennox-Gastaut syndrome in male siblings with a novel DCX mutation and anterior pachygyria. Epilepsia 2010, 51:1902-1905.
73. Lewis H., Wallace S.J. Vigabatrin. Dev Med Child Neurol 2001, 43:833-835.
74. Lortie A., Chiron C., Mumford J., et al. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology 1993, 43:S24-S27.
75. Lux A.L., Edwards S.W., Hancock E., et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14days: a multicentre, randomised controlled trial. Lancet 2004, 364:1773-1778.
76. Lux A.L., Edwards S.W., Hancock E., et al. United Kingdom Infantile Spasms Study. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14months: a multicentre randomised trial. Lancet Neurol 2005, 4:712-717.
77. Mackay M.T., Weiss S.K., Adams-Webber T., et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004, 62:1668-1681.
78. Marescaux C., Hirsch E., Finck S., et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990, 31:768-777.
79. Marini C., Mei D., Cross J.H., et al. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia 2006, 47:1737-1740.
80. Marini C., Mei D., Temudo T., et al. Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 2007, 48:1678-1685.
81. Marini C., Scheffer I.E., Nabbout R., et al. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia 2009, 50:1670-1678.
82. Marshall C.R., Young E.J., Pani A.M., et al. Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11. Am J Hum Genet 2008, 83:106-111.
83. Mei D., Marini C., Novara F., et al. Xp22.3 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy. Epilepsia 2010, 51:647-654.
84. Meisler M.H., Kearney J.A. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 2005, 115:2010-2017.
85. Milh M., Villeneuve N., Chapon F., et al. Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin. J Child Neurol 2009, 24:305-315.
86. Motte J., Trevathan E., Arvidsson J.F., et al. Lamotrigine for generalized seizures associated with Lennox-Gastaut Syndrome. N Engl J Med 1997, 337:1807-1812.
87. Mulley J.C., Scheffer I.E., Petrou S., et al. SCN1A mutations and epilepsy. Hum Mutat 2005, 25:535-542.
88. Mytinger J.R., Quigg M., Taft W.C., et al. Outcomes in treatment of infantile spasms with pulse methylprednisolone. J Child Neurol 2010, 25:948-953.
89. Nabbout R., Gennaro E., Dalla Bernardina B., et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 2003, 60:1961-1967.
90. Neal E.G., Chaffe H., Schwartz R.H., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008, 7:500-506.
91. Nordli D.R., DeVivo D.C. Inherited metabolic disorders. Epilepsy: A Comprehensive Textbook 2008, 2603-2619. Wolters Kluwer, Philadelphia. 2nd edn. J. Engel, T.A. Pedley (Eds.).
92. Oguni H., Olivier A., Andermann F., et al. Anterior callosotomy in the treatment of medically intractable epilepsies: a study of 43 patients with a mean follow-up of 39months. Ann Neurol 1991, 30:357-364.
93. Oguni H., Fukuyama Y., Imaizumi Y., et al. Video-EEG analysis of drop seizures in myoclonic astatic epilepsy of early childhood (Doose syndrome). Epilepsia 1992, 33:805-813.
94. Oguni H., Uehara T., Imai K., et al. Atonic epileptic drop attacks associated with generalized spike-and-slow wave complexes: video-polygraphic study in two patients. Epilepsia 1997, 38:813-818.
95. Oguni H., Hayashi K., Awaya Y., et al. Severe myoclonic epilepsy in infants - a review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev 2001, 23:736-748.
96. Parrini E., Ferrari A.R., Dorn T., et al. Bilateral frontoparietal polymicrogyria, Lennox-Gastaut syndrome, and GPR56 gene mutations. Epilepsia 2009, 50:1344-1353.
97. Patry G., Lyagoubi S., Tassinari C.A. Subclinical "electrical status epilepticus" induced by sleep in children. A clinical and electroencephalographic study of six cases. Arch Neurol 1971, 24:242-252.
98. Pellock J.M., Nordli D.R., Dulac O. Drug treatment in children. Epilepsy: A Comprehensive Textbook 2008, 1249-1257. Wolters Kluwer, Philadelphia. 2nd edn. J. Engel, T.A. Pedley (Eds.).
99. Pellock J.M., Hrachovy R., Shinnar S., et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010, 51:2175-2189.
100. Piccirilli M., D'Alessandro P., Tiacci C., et al. Language lateralization in children with benign partial epilepsy. Epilepsia 1988, 29:19-25.
101. Pulsifer M.B., Brandt J., Salorio C.F., et al. The cognitive outcome of hemispherectomy in 71 children. Epilepsia 2004, 45:243-254.
102. Ragona F., Dalla Bernardina B., Granata T., et al. Cognitive development in Dravet syndrome: a retrospective, multi center study of 26 patients. Epilepsia 2011, 52:386-392.
103. Reiter E., Tiefenthaler M., Freillinger M., et al. Familial idiopathic West syndrome. J Child Neurol 2000, 15:249-252.
104. Riikonen R. Infantile spasms: modern practical aspects. Act Paediatr Scand 1984, 73:1-12.
105. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996, 37:367-372.
106. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001, 23:539-541.
107. Sachdeo R.C., Glauser T.A., Ritter F., et al. Double-blind, randomized trial of topiramate in Lennox-Gastaut Syndrome. Neurology 1999, 52:1882-1887.
108. Saltik S., Kocer N., Dervent A. Informative value of magnetic resonance imaging and EEG in the prognosis of infantile spasms. Epilepsia 2002, 43:246-252.
109. Scheffer I.E., Berkovic S.F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997, 120:479-490.
110. Seri S., Cerquiglini A., Pisani F. Spike-induced interference in auditory sensory processing in Landau-Kleffner syndrome. Electroencephalogr Clin Neurophysiol 1998, 108:506-510.
111. Shewmon D.A., Erwin R.J. Focal spike-induced cerebral dysfunction is related to the after-coming slow wave. Ann Neurol 1988, 23:131-137.
112. Singh R., Scheffer I.E., Crossland K., et al. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999, 45:75-81.
113. Singh R., Andermann E., Whitehouse W.P., et al. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+?. Epilepsia 2001, 42:837-844.
114. Smith M.C., Hoeppner T.J. Epileptic encephalopathy of late childhood: Landau-Kleffner syndrome and the syndrome of continuous spikes and waves during slow-wave sleep. J Clin Neurophysiol 2003, 20:462-472.
115. Striano P., Mancardi M.M., Biancheri R., et al. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations. Epilepsia 2007, 48:1092-1096.
116. Stromme P., Mangelsdorf M.E., Shaw M.A., et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002, 30:441-445.
117. Sugai K., Fukuyama Y., Yasuda K., et al. Clinical and pedigree study on familial cases of West syndrome in Japan. Brain Dev 2001, 123:558-564.
118. Sugawara T., Mazaki-Miyazaki E., Fukushima K., et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 2002, 58:1122-1124.
119. Tassinari C.A., Rubboli G., Volpi L., et al. Electrical status epilepticus during slow sleep (ESES or CSWS) including acquired epileptic aphasia (Landau-Kleffner syndrome). Epileptic Syndromes in Infancy, Childhood and Adolescence 2002, 69-79. John Libbey, London. 3rd edn. J. Roger, M. Bureau, C. Dravet (Eds.).
120. Thelle T., Gammelgaard L., Hansen J.K., et al. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome. Eur J Paediatr Neurol 2011, 15:260-264.
121. Trevathan E., Murphy C.C., Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999, 40:748-751.
122. Vigabatrin Paediatric Advisory Group Guideline for prescribing vigabatrin in children has been revised. BMJ 2000, 320:1404-1405.
123. Vigevano F., Cilio M.R. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized prospective study. Epilepsia 1997, 38:1270-1274.
124. Vigevano F., Fusco L., Cusmai R., et al. The idiopathic form of West syndrome. Epilepsia 1993, 34:743-746.
125. Wallace R.H., Hodgson B.L., Grinton B.E., et al. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 2003, 61:765-769.
126. Wolff M., Cassè-Perrot C., Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006, 47:45-48.
127. Wong M., Trevathan E. Infantile spasms. Pediatr Neurol 2001, 24:89-98.
128. Yakoub M., Dulac O., Jambaqué I., et al. Early diagnosis of severe myoclonic epilepsy in infancy. Brain Dev 1992, 14:299-303.